<table id="id_287b4b49-6995-4233-9304-e05429848a92" rules="all" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_96b1dc6d-2d5e-4784-97b2-b5ebaae3b032">Table 13. HIV-1 RNA Response at Week 48 by Baseline Lopinavir Susceptibility<sup>1</sup>
</caption>
<col width="4277*"></col>
<col width="4505*"></col>
<col width="4238*"></col>
<thead>
<tr id="id_37b75290-92f2-46c0-85a7-cc5fa9dd0c76" stylecode="Botrule">
<td align="left" valign="top">
<content stylecode="bold">Lopinavir susceptibility<sup>2</sup> at baseline</content>
</td>
<td align="center" valign="top">
<content stylecode="bold">HIV-1 RNA &lt;400 copies/mL (%)</content>
</td>
<td align="center" valign="top">
<content stylecode="bold">HIV-1 RNA &lt;50 copies/mL (%)</content>
</td>
</tr>
</thead>
<tfoot id="id_2c10edb8-d80e-427a-86c2-1cce442ca625">
<tr>
<td align="left" colspan="3" valign="top">
<paragraph>1   Lopinavir susceptibility was determined by recombinant phenotypic technology performed by Virologic.</paragraph>
<paragraph>2   Fold change in susceptibility from wild type.</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr id="id_a51345ef-1c21-427d-a135-1e276b8f060b" stylecode="Toprule">
<td align="left" valign="top">&lt; 10 fold </td>
<td align="center" stylecode="Toprule" valign="top">25/27 (93%)</td>
<td align="center" valign="top">22/27 (81%)</td>
</tr>
<tr id="id_aeefe1ac-7aca-4d1e-a945-a8121df02161">
<td align="left" valign="top">&gt; 10 and &lt; 40 fold</td>
<td align="center" valign="top">11/15 (73%)</td>
<td align="center" valign="top">9/15 (60%)</td>
</tr>
<tr id="id_79d9549f-4cca-4e78-8899-2f13ae437d2a">
<td align="left" valign="top">≥ 40 fold</td>
<td align="center" valign="top">2/8 (25%)</td>
<td align="center" valign="top">2/8 (25%)</td>
</tr>
</tbody>
</table>